相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials
Shreya Rao et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2022)
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study
Jose R. Gonzalez-Juanatey et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)
Is Polypill the magic pill?
Aldo Pietro Maggioni
INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)
The Polypill at 20-What Have We Learned?
Thomas J. Wang
NEW ENGLAND JOURNAL OF MEDICINE (2022)
A polypill improves secondary prevention of heart attack
H. Vaillant et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)
Polypill Strategy in Secondary Cardiovascular Prevention
Jose M. Castellano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Polypill with or without Aspirin in Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Disparities in Cardiovascular Research Output and Disease Outcomes among High-, Middle- and Low-Income Countries - An Analysis of Global Cardiovascular Publications over the Last Decade (2008-2017)
Nada Qaisar Qureshi et al.
GLOBAL HEART (2021)
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
Thomas A. Gaziano et al.
AMERICAN HEART JOURNAL (2019)
Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension-a randomised double-blind, placebo controlled crossover study
Piotr Ruszkowski et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2019)
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
Gholamreza Roshandel et al.
LANCET (2019)
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Daniel Munoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes
Sameer Bansilal et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
Jin-Sun Park et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk
Anushka Patel et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Untangling the relationship between medication adherence and post-myocardial infarction outcomes: Medication adherence and clinical outcomes
Niteesh K. Choudhry et al.
AMERICAN HEART JOURNAL (2014)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Fixed-dose combination therapy for the prevention of cardiovascular disease
Angharad N. de Cates et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Statins as Antithrombotic Drugs
Francesco Violi et al.
CIRCULATION (2013)
Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial
Simon Thom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients
Sayed H. Naderi et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases The Second Indian Polycap Study (TIPS-2) Investigators
Salim Yusuf et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Ramipril Sensitizes Platelets to Nitric Oxide Implications for Therapy in High-Risk Patients
Scott R. Willoughby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity
Walid F. Gellad et al.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2011)
Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial
Jose Zamorano et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors
F. Malekzadeh et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
The Use of a Single-Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo-Controlled, Multicenter Study
Joel M. Neutel et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial
S. Yusuf et al.
LANCET (2009)
A strategy to reduce cardiovascular disease by more than 80%
NJ Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
